Sibannac, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- David A. Mersky
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 2122 East Highland Avenue Phoenix AZ United States of America 85016
- IPO Date
- Feb 10, 2014
- CIK
- 0001313938
- Website
- snncinc.com
- Similar Companies
- Business
- Sibannac, Inc. (Ticker: SNNC) is a biotechnology company focused on developing and commercializing innovative nutraceutical and wellness products derived from natural cannabinoids and plant-based compounds. The company offers a range of core products including full-spectrum CBD oils, hemp-derived gummies, topical balms, and pet wellness formulations under its proprietary brands such as Sibannac Pure and Hemp Gold Series; it also provides white-label manufacturing services and custom formulation solutions for retailers and distributors targeting the health supplement and alternative medicine markets. Founded in 2018 and headquartered in Boca Raton, Florida, Sibannac operates primarily in the United States with distribution networks across North America and select international markets in Europe and Asia, serving B2B clients including dispensaries, e-commerce platforms, and wellness brands. In a major strategic shift within the last year, the company completed a significant funding round in Q3 2025, raising $15 million to expand production capacity and launch its new AI-optimized cannabinoid extraction technology; additionally, Sibannac announced a key partnership with a leading European distributor in October 2025 to enter the medical cannabis adjunct market and acquired a complementary hemp processing facility in Colorado to verticalize its supply chain. These developments position Sibannac for accelerated growth amid increasing regulatory clarity in the U.S. hemp industry. The company maintains no major subsidiaries but operates through strategic alliances to enhance its research and development pipeline for novel bioactive compounds.
Sibannac, Inc. Announces Development of Functional Mushroom Products and Moringa to Expand Wellness Portfolio
Sibannac, Inc. (SNNC) Announces Joint Venture With 1120 Management, LLC to Develop State-of-the-Art DEA-Compliant Psilocybin Research Facility in Phoenix, Arizona
Sibannac, Inc. Anticipates Surge In Psychedelic Tourism Following Presidential Executive Order Fast-Tracking Reserarch
Sibannac, Inc. (OTC:SNNC) Announces Strategic Marketing & Revenue Acceleration Partnership With Small Cap Access
Sibannac, Inc. Begins Taking Reservations For Its Ayahuasca Retreat At World-Renowned Rythmia In Costa Rica
Sibannac, Inc. Announces Its Inaugural Plant Medicine Retreat At Rythmia In Costa Rica
Sibannac, Inc. and 4biddenknowledge Forge Strategic Partnership to Accelerate Global Psychedelic Retreats
Sibannac, Inc. and 4biddenknowledge, Inc. Record First Podcast in Planned Series
Sibannac, Inc. and 4biddenknowledge, Inc. Announce Co-Marketing Partnership to Launch Podcasts, Plant-Medicine Retreats, and Innovative Wellness Products
Sibannac, Inc. Announces Luxury Plant-Based Wellness Tourism with U.S. and International Retreats
Sibannac Expands into Booming $1.4 Trillion Wellness Tourism Market with Starwalker Journeys
Sibannac Launches Starwalker Cafe - A Transformational Hub for Consciousness Exploration, Wellness Journeys, and Lifestyle Growth
Sibannac, Inc. and Higher Times Announce Strategic Joint Venture to Expand Consciousness and Wellness Project Offerings
Sibannac, Inc. and Celebrity Television Personality William Henry Announce First Podcast Interview for Starwalker Cafe and Plant Medicine Travel Destinations
Sibannac, Inc. (SNNC) Nears Completion of PCAOB Audit Preparations, Plans SEC Filing
Sibannac, Inc. and Celebrity Television Personality William Henry Launch Groundbreaking Multimedia Community in Partnership with Industry Leading Monetization Innovator
Sibannac, Inc. Introduces Alternative Wellness Brand Cherryology
Sibannac, Inc. Provides New Shareholder Update
Sibannac, Inc. Launches the Campus Community and Details NASDAQ IPO Spin Off Program
Sibannac, Inc. Sets Goals for 2024